Ambrx Biopharma American Stock Last Dividend Paid
Ambrx Biopharma American fundamentals help investors to digest information that contributes to Ambrx Biopharma's financial success or failures. It also enables traders to predict the movement of Ambrx Stock. The fundamental analysis module provides a way to measure Ambrx Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ambrx Biopharma stock.
Ambrx |
Ambrx Biopharma American Company Last Dividend Paid Analysis
Ambrx Biopharma's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Ambrx Biopharma American has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
All Next | Launch Module |
Ambrx Fundamentals
Return On Equity | -0.37 | |||
Return On Asset | -0.19 | |||
Operating Margin | (483.51) % | |||
Current Valuation | 1.56 B | |||
Shares Outstanding | 63.29 M | |||
Shares Owned By Insiders | 2.09 % | |||
Shares Owned By Institutions | 97.91 % | |||
Number Of Shares Shorted | 1.16 M | |||
Price To Earning | 0.19 X | |||
Price To Book | 7.31 X | |||
Price To Sales | 432.96 X | |||
Revenue | 4.09 M | |||
Gross Profit | 7.4 M | |||
EBITDA | (61.75 M) | |||
Net Income | (67.06 M) | |||
Cash And Equivalents | 110.89 M | |||
Cash Per Share | 2.87 X | |||
Total Debt | 11.98 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 4.70 X | |||
Book Value Per Share | 3.85 X | |||
Cash Flow From Operations | (57.7 M) | |||
Short Ratio | 1.21 X | |||
Earnings Per Share | 0.42 X | |||
Price To Earnings To Growth | (0.15) X | |||
Target Price | 28.5 | |||
Number Of Employees | 87 | |||
Beta | -2.36 | |||
Market Capitalization | 1.77 B | |||
Total Asset | 146.98 M | |||
Retained Earnings | (291.63 M) | |||
Working Capital | 73.92 M | |||
Z Score | 85.23 | |||
Net Asset | 146.98 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |